Research Papers

25 of 425 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
NASH Drug Development: Seeing the Light at the End of the Tunnel?
Chen YQ.
J Clin Transl Hepatol (Unknown)
Published: 2023
2/6 Transparent
Integrated Multidisciplinary Management of Alcohol-associated Liver Disease.
Holbeck M; DeVries HS; Singal AK.
J Clin Transl Hepatol (Unknown)
Published: 2023
2/6 Transparent
Molecular Detection of <i>FGFR2</i> Rearrangements in Resected Intrahepatic Cholangiocarcinomas: FISH Could Be An Ideal…
Zou Y; Zhu K; Pang Y; Han J; Zhang X; Jiang Z; Huang Y; Gu W; Ji Y.
J Clin Transl Hepatol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Distinct Types of Cell Death and Implications in Liver Diseases: An Overview of Mechanisms and Application.
Wang Y; Shi C; Guo J; Zhang Y; Gong Z.
J Clin Transl Hepatol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Therapeutic Effect of Prolyl Endopeptidase Inhibitor in High-fat Diet-induced Metabolic Dysfunction-associated Fatty Li…
Zhang JB; Li MT; Lin SZ; Cheng YQ; Fan JG; Chen YW.
J Clin Transl Hepatol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Emerging Evidence Linking the Liver to the Cardiovascular System: Liver-derived Secretory Factors.
Liu X; Shao Y; Han L; Zhang R; Chen J.
J Clin Transl Hepatol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Early but Not Late Exercise Training in Mice Exacerbates Hepatic Inflammation in Developing Nonalcoholic Fatty Liver Di…
Kovynev A; Ying Z; Lambooij JM; van der Zande HJP; Guigas B; Rensen PCN; Schönke M.
J Clin Transl Hepatol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma: Real-life Data on Liver Disease, Treatment and Prognosis.
Adhoute X; Pietri O; Pénaranda G; Wolf T; Beaurain P; Monnet O; Laquière A; Bonomini J; Neumann F; Levrel O; Buono JP; Hanna X; Castellani P; Perrier H; Bourliere M; Anty R.
J Clin Transl Hepatol (Unknown)
Published: 2023
2/6 Transparent
CENPA-driven STMN1 Transcription Inhibits Ferroptosis in Hepatocellular Carcinoma.
Liang D; Luo L; Wang J; Liu T; Guo C.
J Clin Transl Hepatol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Serum Soluble Vascular Endothelial Growth Factor Receptor 1 as a Potential Biomarker of Hepatopulmonary Syndrome.
Li YJ; Wu XF; Wang DD; Li P; Liang H; Hu XY; Gan JQ; Sun YZ; Li JH; Li J; Shu X; Song AL; Yang CY; Yang ZY; Yu WF; Yang LQ; Wang XB; Belguise K; Xia ZY; Yi B.
J Clin Transl Hepatol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Carvedilol Versus Other Nonselective Beta Blockers for Variceal Bleeding Prophylaxis and Death: A Network Meta-analysis.
Cheung KS; Mok CH; Lam LK; Mao XH; Mak LY; Seto WK; Yuen MF.
J Clin Transl Hepatol (Unknown)
Published: 2023
2/6 Transparent
High Frequency of Antiviral Resistance Mutations in HBV Genotypes A2 and H: Multidrug Resistance Strains in Mexico.
Jose-Abrego A; Roman S; Rebello Pinho JR; Gomes-Gouvêa MS; Panduro A.
J Clin Transl Hepatol (Unknown)
Published: 2023
4/6 Transparent
Data Funding Declared
Noninvasive Fibrosis Assessment in Chronic Hepatitis C Infection: An Update.
Bojanic K; Bogojevic MS; Vukadin S; Sikora R; Ivanac G; Lucic NR; Smolic M; Tabll AA; Wu GY; Smolic R.
J Clin Transl Hepatol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Activation of NLRP3 Inflammasome via Drp1 Overexpression in Kupffer Cells Aggravates Ischemia-reperfusion Injury in Hep…
Zhang L; Wang M; An R; Dai J; Liu S; Chen M; Ding H.
J Clin Transl Hepatol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
High-intensity Interval Training for the Management of Nonalcoholic Steatohepatitis: Participant Experiences and Perspe…
Keating SE; Croci I; Wallen MP; Cox ER; Coombes JS; Burton NW; Macdonald GA; Hickman IJ.
J Clin Transl Hepatol (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Community-centered Disease Severity Assessment of Metabolic Dysfunction-associated Fatty Liver Disease.
Huang JF; Tsai PC; Yeh ML; Huang CF; Huang CI; Lee MH; Hsu PY; Wang CW; Wei YJ; Liang PC; Lin YH; Hsieh MH; Yang JF; Hsieh MY; Jang TY; Bair MJ; Lin ZY; Dai CY; Yu ML; Chuang WL.
J Clin Transl Hepatol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Dysregulation of PLOD2 Promotes Tumor Metastasis and Invasion in Hepatocellular Carcinoma.
Li K; Niu Y; Li K; Zhong C; Qiu Z; Yuan Y; Shi Y; Lin Z; Huang Z; Zuo D; Yuan Y; Li B.
J Clin Transl Hepatol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Secondary Iron Overload and the Liver: A Comprehensive Review.
Pinyopornpanish K; Tantiworawit A; Leerapun A; Soontornpun A; Thongsawat S.
J Clin Transl Hepatol (Unknown)
Published: 2023
2/6 Transparent
Targeting Gut Microbiota for the Treatment of Primary Biliary Cholangitis: From Bench to Bedside.
Zhang L; Yang L; Chu H.
J Clin Transl Hepatol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Performance of the Enhanced Liver Fibrosis Score, Comparison with Vibration-controlled Transient Elastography Data, and…
Reinson T; Patel J; Mathews M; Fountain D; Buchanan RM; Byrne CD.
J Clin Transl Hepatol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Single-cell RNA-seq Revealed that Altered Tumor Infiltrating Lymphocytes in Cirrhotic Liver Indicate Development of Hep…
Duan J; Zhu P; Zhang Y; Mu T; Li Y; Xiong R; Chen S; Li Y; Li Z; Chen S; Zhang L.
J Clin Transl Hepatol (Unknown)
Published: 2023
4/6 Transparent
Data Funding Declared
Comparison of Clinical Characteristics and Outcomes of MAFLD and NAFLD in Chinese Health Examination Populations.
Xu X; Zhou X; Tian T; Ding Y; Yu C; Zhao W; Wang X; Lu J; Guo W; Jiang L; Wang Q; Zhang Q; Song C.
J Clin Transl Hepatol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Primary Hepatic Extra-gastrointestinal Stromal Tumors: Molecular Pathogenesis, Immunohistopathology, and Treatment.
Becker EC; Ozcan G; Wu GY.
J Clin Transl Hepatol (Unknown)
Published: 2023
2/6 Transparent
Metabolic Phenotypes: Drivers of Health Outcomes in Fatty Liver Diseases.
Charatcharoenwitthaya P.
J Clin Transl Hepatol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Aminoacyl-tRNA Synthetase-based Prognosis Model and Exploration of Potential Mechanisms in Hepatocellular Carcinoma.
Jin Y; Huang X; Wang Z; Xu H; Wang Q; Wang L.
J Clin Transl Hepatol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared